Market Cap (In CNY)
3.21 Billion
Revenue (In CNY)
2.77 Billion
Net Income (In CNY)
103.39 Million
Avg. Volume
8.33 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.76-5.94
- PE
- -
- EPS
- -
- Beta Value
- 0.41
- ISIN
- CNE000001H03
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Ya Qi Dou
- Employee Count
- -
- Website
- https://www.gzcci.com
- Ipo Date
- 2004-03-23
- Details
- Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.
More Stocks
-
RFKRafako S.A.
RFK
-
002069Zoneco Group Co., Ltd.
002069
-
ERA
-
TSRYF
-
WELCORPWelspun Corp Limited
WELCORP
-
YUMAQYuma Energy, Inc.
YUMAQ
-
RAJPUTANARajputana Investment and Finan
RAJPUTANA
-
STANCAPStandard Capital Markets Limited
STANCAP